Sales - Hospital Sales Representative Daiichi Sankyo Employee Review

3.0
Apr 6, 2016
Recommend
CEO approval
Business Outlook

Pros

This company taught me a lot about the pharma industry. I received a great deal of cardio experience while at DSI.

Cons

The company had a massive layoff in 2016 due to our block buster drug Benicar went generic in January of 2016. In addition our new Factor Xa drug we launched was not going well so 60% layoffs were the result.

Explore other reviews about Daiichi Sankyo

5.0
Jun 3, 2026
Recommend
CEO approval
Business Outlook

Pros

Great culture. Good people. Exciting trials. Well funded.

Cons

New pipeline is lacking but they are taking steps

4.0
Jul 10, 2026
Recommend
CEO approval
Business Outlook

Pros

Great culture and people, compensation is good. Feel I make a difference

Cons

Hard to get promoted and too many detailed processes

See reviews by: Helpful|Rating|Date|All